Diffusion Pharmaceuticals Stock Forecast - Naive Prediction

DFFNDelisted Stock  USD 3.27  0.17  5.48%   
The Naive Prediction forecasted value of Diffusion Pharmaceuticals on the next trading day is expected to be 3.42 with a mean absolute deviation of 0.10 and the sum of the absolute errors of 6.26. Diffusion Stock Forecast is based on your current time horizon.
  
A naive forecasting model for Diffusion Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Diffusion Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Diffusion Pharmaceuticals Naive Prediction Price Forecast For the 25th of November

Given 90 days horizon, the Naive Prediction forecasted value of Diffusion Pharmaceuticals on the next trading day is expected to be 3.42 with a mean absolute deviation of 0.10, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.26.
Please note that although there have been many attempts to predict Diffusion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Diffusion Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Diffusion Pharmaceuticals Stock Forecast Pattern

Backtest Diffusion PharmaceuticalsDiffusion Pharmaceuticals Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Diffusion Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Diffusion Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.9683
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1027
MAPEMean absolute percentage error0.0287
SAESum of the absolute errors6.2631
This model is not at all useful as a medium-long range forecasting tool of Diffusion Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Diffusion Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Diffusion Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diffusion Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
3.273.273.27
Details
Intrinsic
Valuation
LowRealHigh
2.892.893.60
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Diffusion Pharmaceuticals. Your research has to be compared to or analyzed against Diffusion Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Diffusion Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Diffusion Pharmaceuticals.

Diffusion Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Diffusion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Diffusion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Diffusion Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Diffusion Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Diffusion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Diffusion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Diffusion Pharmaceuticals stock market strength indicators, traders can identify Diffusion Pharmaceuticals entry and exit signals to maximize returns.

Diffusion Pharmaceuticals Risk Indicators

The analysis of Diffusion Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Diffusion Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting diffusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Diffusion Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diffusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Diffusion Stock

  0.66TCHH Trustcash HoldingsPairCorr
  0.77SHG Shinhan FinancialPairCorr

Moving against Diffusion Stock

  0.87BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.81JPM JPMorgan Chase Fiscal Year End 10th of January 2025 PairCorr
  0.81CSCO Cisco Systems Aggressive PushPairCorr
  0.79WMT Walmart Aggressive PushPairCorr
  0.79AXP American Express Fiscal Year End 24th of January 2025 PairCorr
The ability to find closely correlated positions to Diffusion Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diffusion Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diffusion Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diffusion Pharmaceuticals to buy it.
The correlation of Diffusion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diffusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diffusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diffusion Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Diffusion Stock

If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.